Marjolein van Zummeren

Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands

Maaike G. Dijkstra, Marjolein van Zummeren, Lawrence Rozendaal et al. · BMJ · 2016 · 126 citations · Full text

Medicine, Gynecology, Preventive Medicine +17

<i>CADM1</i> , <i>MAL</i> and <i>miR124-2</i> methylation analysis in cervical scrapes to detect cervical and endometrial cancer

Lise M.A. De Strooper, Marjolein van Zummeren, Renske D.M. Steenbergen et al. · Journal of Clinical Pathology · 2014 · 97 citations · Full text

Medicine, Molecular Biology, Oncology +17

HPV E4 expression and DNA hypermethylation of CADM1, MAL, and miR124-2 genes in cervical cancer and precursor lesions

Marjolein van Zummeren, Wieke W. Kremer, Annemiek Leeman et al. · Modern Pathology · 2018 · 66 citations · Full text

Medicine, Oncology, Pathology +17

Three-tiered score for Ki-67 and p16 ^ink4a improves accuracy and reproducibility of grading CIN lesions

Marjolein van Zummeren, Annemiek Leeman, Wieke W. Kremer et al. · Journal of Clinical Pathology · 2018 · 48 citations · Full text

Medicine, Oncology, Pathology +17

The use of molecular markers for cervical screening of women living with HIV in South Africa

Wieke W. Kremer, Marjolein van Zummeren, Erika Breytenbach et al. · AIDS · 2019 · 32 citations · Full text

Medicine, Gynecology, Pathology +17